Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Crossref DOI link: https://doi.org/10.1007/s10120-015-0457-4
Published Online: 2015-01-21
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Jinwan
Xu, Ruihua
Li, Jian
Bai, Yuxian
Liu, Tianshu
Jiao, Shunchang
Dai, Guanghai
Xu, Jianming
Liu, Yunpeng
Fan, Nanfeng
Shu, Yongqian
Ba, Yi
Ma, Dong
Qin, Shukui
Zheng, Leizhen
Chen, Weichang
Shen, Lin
License valid from 2015-01-21